X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3931) 3931
Newsletter (205) 205
Newspaper Article (85) 85
Magazine Article (22) 22
Book Chapter (16) 16
Dissertation (9) 9
Transcript (9) 9
Publication (5) 5
Conference Proceeding (3) 3
Streaming Video (2) 2
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aripiprazole (3882) 3882
science & technology (2534) 2534
life sciences & biomedicine (2464) 2464
humans (2224) 2224
psychiatry (1713) 1713
male (1375) 1375
antipsychotic agents - therapeutic use (1372) 1372
female (1207) 1207
pharmacology & pharmacy (1169) 1169
piperazines - therapeutic use (1136) 1136
schizophrenia (1133) 1133
quinolones - therapeutic use (1122) 1122
adult (1021) 1021
antipsychotic agents - adverse effects (997) 997
neurosciences & neurology (779) 779
schizophrenia - drug therapy (766) 766
piperazines - adverse effects (733) 733
quinolones - adverse effects (720) 720
middle aged (642) 642
treatment outcome (602) 602
neurosciences (598) 598
clinical neurology (565) 565
drug therapy (506) 506
antipsychotic agents - administration & dosage (496) 496
adolescent (482) 482
olanzapine (459) 459
psychotropic drugs (443) 443
antipsychotic agents - pharmacology (408) 408
risperidone (396) 396
animals (381) 381
antipsychotic drugs (376) 376
bipolar disorder (359) 359
research (359) 359
piperazines - administration & dosage (347) 347
quinolones - administration & dosage (341) 341
piperazines - pharmacology (328) 328
mental disorders (327) 327
quinolones - pharmacology (315) 315
drug therapy, combination (310) 310
care and treatment (307) 307
dose-response relationship, drug (307) 307
neuroleptics (303) 303
analysis (300) 300
young adult (300) 300
dopamine (294) 294
antipsychotics (285) 285
dosage and administration (285) 285
bipolar disorder - drug therapy (284) 284
psychotic disorders - drug therapy (271) 271
aripiprazole - therapeutic use (259) 259
child (258) 258
quetiapine (258) 258
clozapine (248) 248
medical research (248) 248
aged (240) 240
social sciences (240) 240
psychology (234) 234
risperidone - therapeutic use (233) 233
medicine, experimental (230) 230
psychiatric status rating scales (228) 228
drugs (223) 223
clinical trials (215) 215
double-blind method (210) 210
mental health (208) 208
aripiprazole - adverse effects (205) 205
patients (203) 203
benzodiazepines - therapeutic use (198) 198
risk factors (195) 195
antipsychotic (194) 194
haloperidol (193) 193
antidepressants (190) 190
aripiprazole - administration & dosage (187) 187
rats (185) 185
health aspects (183) 183
pediatrics (182) 182
complications and side effects (172) 172
psychosis (170) 170
quetiapine fumarate (161) 161
medicine & public health (159) 159
ziprasidone (159) 159
risperidone - adverse effects (155) 155
internal medicine (153) 153
pharmacology (151) 151
depressive disorder, major - drug therapy (142) 142
time factors (142) 142
psychopharmacology (141) 141
drug administration schedule (139) 139
randomized controlled trials as topic (136) 136
aripiprazole - pharmacology (135) 135
benzodiazepines - adverse effects (135) 135
psychology, clinical (135) 135
studies (132) 132
pharmacology/toxicology (131) 131
schizophrenic psychology (126) 126
pharmacotherapy (122) 122
antidepressive agents - therapeutic use (121) 121
dibenzothiazepines - therapeutic use (121) 121
children (118) 118
usage (117) 117
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4076) 4076
French (44) 44
Turkish (44) 44
German (38) 38
Japanese (31) 31
Spanish (26) 26
Italian (23) 23
Portuguese (18) 18
Chinese (17) 17
Hungarian (12) 12
Dutch (11) 11
Polish (11) 11
Czech (8) 8
Russian (6) 6
Danish (2) 2
Arabic (1) 1
Korean (1) 1
Norwegian (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Psychopharmacology, ISSN 0033-3158, 07/2019, Volume 236, Issue 7, p. 2283
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 12/2016, Volume 59, Issue 23, pp. 10601 - 10618
Biased ligands (also known as functionally selective ligands) of G protein-coupled receptors are valuable tools for dissecting the roles of G protein-dependent... 
Dose-Response Relationship, Drug | Aripiprazole - pharmacology | Humans | Receptors, Dopamine D2 - agonists | HEK293 Cells | Aripiprazole - chemistry | Ligands | Aripiprazole - chemical synthesis | Molecular Structure | Structure-Activity Relationship | Drug Discovery | GTP-Binding Proteins - metabolism | Index Medicus
Journal Article
Psychopharmacology, ISSN 0033-3158, 1/2018, Volume 235, Issue 1, pp. 245 - 255
The use of second-generation antipsychotics (SGA) has been associated with metabolic changes. However, there are differences in the metabolic profile between... 
Medication-naïve | Neurosciences | Biomedicine | Second-generation antipsychotic | Triglycerides | Glucose | Pharmacology/Toxicology | Psychiatry | Weight gain | Cholesterol | Pharmacology & Pharmacy | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Body Weight - drug effects | Male | Thiazoles - therapeutic use | Thiazoles - adverse effects | Aripiprazole - adverse effects | Young Adult | Dibenzothiazepines - therapeutic use | Antipsychotic Agents - therapeutic use | Quinolones - therapeutic use | Aripiprazole - therapeutic use | Adult | Female | Quetiapine Fumarate - pharmacology | Body Mass Index | Quetiapine Fumarate - adverse effects | Piperazines - therapeutic use | Cholesterol - metabolism | Piperazines - adverse effects | Piperazines - pharmacology | Quetiapine Fumarate - therapeutic use | Triglycerides - metabolism | Blood Glucose - drug effects | Psychotic Disorders - metabolism | Aripiprazole - pharmacology | Psychotic Disorders - drug therapy | Thiazoles - pharmacology | Antipsychotic Agents - pharmacology | Drugs | Lipoproteins (low density) | Obesity | Neuroleptics | Mental disorders | Ziprasidone | Clinical trials | Aripiprazole | Metabolism | Patients | Psychosis | Psychotropic drugs | Hypercholesterolemia | Body mass | Hypertriglyceridemia | Psychopharmacology | Lipoproteins (high density) | Quetiapine | Index Medicus
Journal Article
Journal of the American Academy of Child and Adolescent Psychiatry, ISSN 0890-8567, 02/2015, Volume 54, Issue 2, pp. 126 - 137.e1
Journal Article
Journal of the American Academy of Child and Adolescent Psychiatry, ISSN 0890-8567, 11/2009, Volume 48, Issue 11, pp. 1110 - 1119
Abstract Objective To evaluate the short-term efficacy and safety of aripiprazole in the treatment of irritability in children and adolescents with autistic... 
Pediatrics | Psychiatry | pediatric. Clinical trial registration information—Study of Aripiprazole in the Treat ment of Children and Adolescents With Autistic Disorder (AD). URL: http://clinicaltrials.gov. Unique identifier: NCT00337571 | aripiprazole | autistic disorder | pediatric. Clinical trial registration information-Study of Aripiprazole in the Treat ment of Children and Adolescents With Autistic Disorder (AD). URL: http://clinicaltrials.gov. Unique identifier: NCT00337571 | Social Sciences | Life Sciences & Biomedicine | Psychology | Psychology, Developmental | Science & Technology | Caregivers | Aggression | Check Lists | Drug Therapy | Disabilities | Self Destructive Behavior | Personality Measures | Allied Health Personnel | Autism | Safety | Evaluation Methods | Children | Adolescents | Piperazines - administration & dosage | Psychomotor Agitation - diagnosis | Child Behavior Disorders - drug therapy | Antipsychotic Agents - adverse effects | Humans | Psychomotor Agitation - psychology | Male | Self-Injurious Behavior - diagnosis | Irritable Mood - drug effects | Aripiprazole | Psychomotor Agitation - drug therapy | Dose-Response Relationship, Drug | Quinolones - adverse effects | Female | Autistic Disorder - diagnosis | Child | Child Behavior Disorders - psychology | Child Behavior Disorders - diagnosis | Double-Blind Method | Drug Administration Schedule | Adverse Drug Reaction Reporting Systems | Self-Injurious Behavior - psychology | Self-Injurious Behavior - drug therapy | Personality Assessment | Treatment Outcome | Piperazines - adverse effects | Autistic Disorder - psychology | Antipsychotic Agents - administration & dosage | Quinolones - administration & dosage | Adolescent | Autistic Disorder - drug therapy | Placebos | Usage | Care and treatment | Dosage and administration | Child psychology | Teenagers | Antidepressants | Effectiveness studies | Index Medicus
Journal Article
Journal Article
European journal of clinical pharmacology, ISSN 0031-6970, 3/2016, Volume 72, Issue 3, pp. 285 - 293
Journal Article